A Network Pharmacology-Based Approach to Investigate the Novel TCM Formula against Huntington’s Disease and Validated by Support Vector Machine Model

<div>The changes of ligand gyrate, MSD, and SASA during MD simulation trajectory. Some of the ligand names were shown in Figure <a href="../fig9/">9</a>. Receptors: (a) CK2A2; (b) mtHSP70; (c) STK3; (d) LATS1.</div>

Evidence-Based Complementary and Alternative Medicine

fig13

Figure 13

Figure 13: A Network Pharmacology-Based Approach to Investigate the Novel TCM Formula against Huntington’s Disease and Validated by Support Vector Machine Model 

Figure 13 | A Network Pharmacology-Based Approach to Investigate the Novel TCM Formula against Huntington’s Disease and Validated by Support Vector Machine Model 